Owkin unveils biology-focused AI agents for clinical research and drug discovery

SiliconANGLE·Jan 12

This story is reported by SiliconANGLE. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Owkin Launches Agentic AI Infrastructure for Biology at JPM Healthcare Conference

HPCwire·Jan 12

2

Advancing Claude in healthcare and the life sciences

Anthropic·Jan 11

3

Owkin's Specialized Biological AI Agent Pathology Explorer Launches with Anthropic's Claude for Healthcare and Life Sciences

Business Wire·Jan 12

4

JPM26: Anthropic launches Claude for Healthcare to turbocharge AI efficiency at health systems, payers

Fierce Healthcare·Jan 11

5

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Business Wire·May 23

6

Owkin announces multi-year strategic collaboration with Bristol Myers Squibb

ActuIA·Jun 27

7

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

Business Wire·Jan 30

8

Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x

Business Wire·May 6